Yingli Wu

22PUBLICATIONS

47CO-AUTHORS

Molecular targetsMetabolic medicinePredictive and prognostic markersMechanobiologyCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|Jun 29, 2026

TRMT1-mediated tRNA m<sup>2</sup><sub>2</sub>G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma.

|Jun 10, 2026

The disulfonic acid ANDS disrupts ANP32B-p53 interaction to suppress chronic myeloid leukemia.

|Sep 24, 2025

USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ.

Hao Luo, Chujiao Zhu, Yingying Wang

|Sep 11, 2025

Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer.

Jun Lu, Minjuan Hu, Yikai Zhao

|Feb 22, 2024

Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma.

Xingming Zhang, Lou Geng, Yi Tang

|Dec 16, 2023

USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia.

Hu Lei, Hanzhang Xu, Li Yang

Pageof 4

Frequent Collaborators

Hu Lei

Qun-Ying Lei

Hua Yan

Zheng-Jun Chen

Guo-Qiang Chen

Yu-Dong Xu

Zhijian Xu

Zhaoqiang Chen

Weiliang Zhu

Guang-Bo Ge

Frequent Collaborators

Hu Lei

Qun-Ying Lei

Hua Yan

Zheng-Jun Chen